Systematic review and meta-analysis: Prognostic impact of time from diagnosis to treatment in patients with acute myeloid leukemia.
Stephanie FrancoXue GengValeriy KorostyshevskiyJudith E KarpCatherine E LaiPublished in: Cancer (2023)
Results were highly variable but suggest it may be feasible to pursue cytogenetic/molecular testing in patients who are clinically stable, particularly in those aged 60 years and older.
Keyphrases
- acute myeloid leukemia
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- physical activity
- middle aged
- patient reported outcomes
- community dwelling
- allogeneic hematopoietic stem cell transplantation
- combination therapy
- patient reported
- acute lymphoblastic leukemia
- replacement therapy